HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Therapeutics in dementia

Therapeutics in dementia

Therapeutics in dementia is the area of research and medical practice that focuses on the treatment and management of dementia symptoms, as well as providing supportive care to dementia patients and their families. Dementia is a neurological disorder that affects a person’s cognitive and social functioning, and is one of the major causes of disability in older adults. Much of the focus of dementia treatment is on helping to maintain and improve the patient’s cognitive abilities, and to delay the progression of the disease. Medication is an important part of dementia treatment. Commonly prescribed medications target certain neurotransmitters thought to be involved in the development of dementia, such as cholinesterase inhibitors and memantine. These medications are used to improve symptoms of cognitive decline, such as memory loss and difficulty with abstract thinking. Research is ongoing to develop new medications, and to identify potential benefits of combining certain medications with lifestyle interventions such as nutrition and exercise. In addition to medication, psychosocial therapies such as cognitive-behavioral therapy can help to reduce agitation, behavior issues, and improve family functioning and quality of life in dementia patients. This type of therapy focuses on helping people understand and modify their thoughts and behaviors in order to better cope with the challenges of living with dementia. Other non-pharmacological interventions such as music or art therapy can also help to improve quality of life. These activities promote relaxation, provide distraction from difficult dementia symptoms, and can be beneficial in stimulating cognitive abilities. Finally, supportive and palliative care are important facets of dementia therapy. This includes providing physical and emotional support to patients and families, as well as end-of-life care to those who have reached a more advanced stage of the illness. Supportive care is focused on maintaining quality of life, and helping families cope during difficult times. Therapeutics in dementia is a continually evolving field, with research is ongoing to identify safe and effective treatment and management strategies for dementia patients.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States
Tags

Submit your abstract Today

Watsapp